Business Context and Reporting Period
This Form 8-K was filed by Inmune Bio, Inc. on September 27, 2021. The company is incorporated in Nevada and its common stock trades on The NASDAQ Stock Market LLC under the symbol INMB. The filing reports an "Other Event" regarding a scheduled corporate presentation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces a scheduled participation in an industry conference panel.
Guidance, Outlook, and Management Commentary
Upcoming Event: Mark Lowdell, PhD, the Company's Chief Scientific Officer and Chief Medical Officer, is scheduled to participate in an oncology panel at the B. Riley Fall 2021 Best Ideas in Oncology Series.
- Panel Title: Improving Strategies to Harness the Immune System
- Date: Thursday, September 30, 2021
- Time: 9:00am ET
A press release detailing this event is included as Exhibit 99.1. The filing contains no specific financial guidance, risk updates, or contingencies beyond the standard disclosure of the event.
Investor Verification Checklist
- Verify the date and time of the B. Riley Fall 2021 Best Ideas in Oncology Series panel (September 30, 2021, 9:00am ET).
- Confirm the participation of Mark Lowdell, PhD, as the presenting executive.
- Review the attached press release (Exhibit 99.1) for additional context on the presentation topic.
- Note that this filing does not contain updated financial results; refer to the most recent 10-Q or 10-K for financial data.